Chemours (CC) vs Innospec (IOSP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Innospec (IOSP) has outperformed Chemours (CC) over the past year, gaining 4.8% versus a loss of 1.5%. Over five years, IOSP leads with a -9.2% price change compared with -64.7% for CC. Innospec is the larger company by market cap ($1.86 billion vs $1.64 billion), about 1.1 times the size, while Chemours is growing revenue faster (+0.4% vs -3.7%).
On valuation, Chemours trades at a lower forward P/E (6.3x vs 12.7x for Innospec). Chemours offers the higher dividend yield (3.22% vs 2.37%). Innospec converts more of its revenue into profit, with a net margin of 6.6% versus -6.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CC | IOSP |
|---|---|---|
| Share price | $10.88 | $75.56 |
| Market cap | $1.64B | $1.86B |
| 1-day change | -7.80% | -1.97% |
| YTD return | -7.72% | -1.28% |
| 1-year return | -1.54% | +4.76% |
| 5-year return | -64.73% | -9.17% |
| P/E ratio (TTM) | — | 13.35 |
| Forward P/E | 6.31 | 12.66 |
| EPS (TTM) | $-1.12 | $5.66 |
| Dividend yield | 3.22% | 2.37% |
| Annual dividend | $0.35 | $1.79 |
| Revenue (latest FY) | $5.81B | $1.78B |
| Revenue growth (YoY) | +0.45% | -3.65% |
| Net income (latest FY) | $-386.00M | $116.60M |
| Gross margin | 15.53% | 27.69% |
| Operating margin | — | 7.28% |
| Net margin | -6.65% | 6.56% |
| 52-week high | $28.67 | $102.00 |
| 52-week low | $10.83 | $65.51 |
| Distance from 52-week high | -62.05% | -25.92% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +47.06% | +31.46% |
| Average volume | 2.14M | 235.15K |
| Shares outstanding | 150.52M | 24.63M |
| Employees | 5,700 | 2,450 |
| Sector | Industrials | Industrials |
| Industry | Major Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Innospec is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -6.6 cents for Chemours.
About Chemours
CC stock →The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.
Industrials · Major Chemicals · 5,700 employees
About Innospec
IOSP stock →Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.
Industrials · Major Chemicals · 2,450 employees
CC vs IOSP FAQ
Which is bigger, Chemours or Innospec?
Innospec (IOSP) is larger, with a market capitalization of $1.86B compared with $1.64B for Chemours (CC).
Which stock has performed better over the past year, CC or IOSP?
IOSP returned +4.76% over the past 12 months, compared with -1.54% for CC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Chemours or Innospec?
Chemours has the higher yield at 3.22%, compared with 2.37% for Innospec.
Are Chemours and Innospec in the same industry?
Yes. Both are classified in the Major Chemicals industry within the Industrials sector.